The data shows a forecasted increase in the mortality rate of prostate malignant neoplasms in Poland from 34.5 male deaths per hundred thousand men in 2024 to 37.6 in 2028. Comparing 2024 to the prior year indicates a 2.7% increase, with further year-on-year rises of 2.3% to 2025, 2.0% to 2026, 2.2% to 2027, and 2.2% to 2028. From 2023 to 2024, there was an increase, and the Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 2.3%.
Future trends to watch for include advancements in medical treatments, early detection methods, and public health initiatives that could influence these mortality rates. Monitoring the impact of healthcare policies and demographic changes on these figures will also be crucial.
